{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:05:12Z","timestamp":1761663912422,"version":"3.37.3"},"reference-count":37,"publisher":"Wiley","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Ophthalmology"],"published-print":{"date-parts":[[2019,4,16]]},"abstract":"<jats:p><jats:italic>Aims<\/jats:italic>. To examine possible benefits of intravitreal anti-vascular endothelial growth factor (VEGF) agent treatment immediately after cataract surgery for patients with diabetic retinopathy (DR). <jats:italic>Methods<\/jats:italic>. A comprehensive literature search was performed using the Cochrane collaboration methodology to identify randomized controlled trials (RCTs) and comparative studies of cataract surgery with or without anti-VEGF agent treatment for any diabetic retinopathy. Meta-analyses were performed for clinical outcome parameters including changes in macular thickness (MT), best-corrected visual acuity (BCVA), incidence of diabetic retinopathy and maculopathy progression, laser treatment rate, and other complications. <jats:italic>Results<\/jats:italic>. Nine RCTs and 3 nonrandomized comparative studies were identified and used for comparing cataract surgery with intravitreal bevacizumab (IVB) or intravitreal ranibizumab (IVR) treatment (338 eyes, intervention group) to cataract surgery alone (329 eyes, control group). Analysis of all data showed that the mean BCVA at 1 week postoperatively had no statistically significant difference in the two groups, but at 1, 3, and 6 months postoperatively, the mean BCVA was statistically significantly better in the anti-VEGF treatment group than that in cataract surgery alone group. Analysis of all data showed that the mean MT was statistically significantly less in the anti-VEGF treatment group at 1 week and 1, 3, and 6 months postoperatively (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\"><mml:mrow><mml:mi>P<\/mml:mi><mml:mo>=<\/mml:mo><mml:mn>0.05<\/mml:mn><\/mml:mrow><\/mml:math>, <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\"><mml:mrow><mml:mi>P<\/mml:mi><mml:mo>=<\/mml:mo><mml:mn>0.006<\/mml:mn><\/mml:mrow><\/mml:math>, <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\"><mml:mrow><mml:mi>P<\/mml:mi><mml:mo>=<\/mml:mo><mml:mn>0.0001<\/mml:mn><\/mml:mrow><\/mml:math>, and <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\"><mml:mrow><mml:mi>P<\/mml:mi><mml:mo>=<\/mml:mo><mml:mn>0.0001<\/mml:mn><\/mml:mrow><\/mml:math>, respectively); but postoperative clinical outcomes were differentiated from the type of anti-VEGF agents, IVB or IVR, and the existing macular edema preoperatively. Intravitreal anti-VEGF agent treatment statistically significantly reduced the incidence of diabetic retinopathy progression and maculopathy progression compared to the control group (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M5\"><mml:mrow><mml:mi>P<\/mml:mi><mml:mo>=<\/mml:mo><mml:mn>0.0003<\/mml:mn><\/mml:mrow><\/mml:math>, <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M6\"><mml:mrow><mml:mi>P<\/mml:mi><mml:mo>&lt;<\/mml:mo><mml:mn>0.00001<\/mml:mn><\/mml:mrow><\/mml:math>, respectively). <jats:italic>Conclusion<\/jats:italic>. IVB or IVR treatment immediately after cataract surgery may represent a safe and effective strategy to prevent postoperative macular thickening or reduce macular edema and result in greater mean improvements in visual acuity for diabetic patients.<\/jats:p>","DOI":"10.1155\/2019\/2648267","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T19:57:31Z","timestamp":1555444651000},"page":"1-10","source":"Crossref","is-referenced-by-count":21,"title":["A Systematic Review and Meta-Analysis of Clinical Outcomes of Intravitreal Anti-VEGF Agent Treatment Immediately after Cataract Surgery for Patients with Diabetic Retinopathy"],"prefix":"10.1155","volume":"2019","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4903-0561","authenticated-orcid":true,"given":"Li-Quan","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Pudong New Area People\u2019s Hospital Affiliated to Shanghai University of Medicine & Health Sciences, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Wei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.08.053"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.5.565"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/126984"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.087403"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.07.014"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/s0886-3350(02)01243-9"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12720"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-300674"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.02.022"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007419.pub5"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2011.0069"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.2010.1405"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.01.014"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1097\/iae.0b013e31819c6302"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2008.09.019"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1097\/iae.0b013e3182979b9e"},{"key":"17","first-page":"880","volume":"15","year":"2015","journal-title":"Guoji Yanke Zazhi"},{"key":"18","first-page":"560","volume":"32","year":"2014","journal-title":"Chinese Journal of Practical Ophthalmology"},{"key":"19","first-page":"754","volume":"36","year":"2016","journal-title":"Recent Advances in Ophthalmology"},{"key":"20","first-page":"149","volume":"8","year":"2016","journal-title":"China Continuing Medical Education"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2008.0068"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/159436"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7121.1533"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2010.189514"},{"volume-title":"Defining the review question and developing criteria for including studies","year":"2008","key":"25"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.04.026"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.11.021"},{"key":"28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archopht.125.4.469","volume":"125","year":"2007","journal-title":"Archives of Ophthalmology"},{"key":"29","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ophtha.2008.06.015","volume":"115","year":"2008","journal-title":"Ophthalmology"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13574"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(99)90148-3"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.03.003"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2009.01817.x"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1159\/000331322"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000523"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.148874"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3819-2"}],"container-title":["Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/joph\/2019\/2648267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/joph\/2019\/2648267.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/joph\/2019\/2648267.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T19:57:33Z","timestamp":1555444653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/joph\/2019\/2648267\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":37,"alternative-id":["2648267","2648267"],"URL":"https:\/\/doi.org\/10.1155\/2019\/2648267","relation":{},"ISSN":["2090-004X","2090-0058"],"issn-type":[{"type":"print","value":"2090-004X"},{"type":"electronic","value":"2090-0058"}],"subject":[],"published":{"date-parts":[[2019,4,16]]}}}